Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | GAA | P10253 | 6/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | CRHBP | P24387 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20319938 | 0.89 | TSHR (0.56) | TSHRGAAKMT2AMEN1HPGD | |
| SCHEMBL10027975 | 0.84 | KDM4E (0.63) | TSHRGAAKMT2AMEN1HPGD | |
| SCHEMBL14643391 | 0.84 | KDM4E (0.63) | TSHRGAAKMT2AMEN1HPGD | |
| SCHEMBL12125203 | 0.84 | MEN1 (0.56) | TSHRGAAKMT2AMEN1HPGD | |
| SCHEMBL7723381 | 0.84 | GAA (0.59) | TSHRGAAKMT2AMEN1HPGD | |
| SCHEMBL26792805 | 0.83 | GAA (0.54) | TSHRGAAKMT2AMEN1HPGD | |
| SCHEMBL12125205 | 0.82 | KMT2A (0.55) | TSHRGAAKMT2AMEN1HPGD | |
| SCHEMBL10447471 | 0.79 | TP53 (0.67) | GAAKMT2AMEN1HPGDMAPT | |
| SCHEMBL10359021 | 0.79 | HPGD (0.51) | TSHRGAAKMT2AMEN1HPGD | |
| SCHEMBL326866 | 0.79 | GAA (0.54) | TSHRGAAKMT2AMEN1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115232020-A | Method for synthesizing N, N-diethyl-2-hydroxyphenylacetamide and analogue thereof and application thereof | 百新(北京)药业科技有限责任公司 | 2022-10-25 | — | — | CN | claimed |
| CN-115232020-A | Method for synthesizing N, N-diethyl-2-hydroxyphenylacetamide and analogue thereof and application thereof | 百新(北京)药业科技有限责任公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-115232020-A | Method for synthesizing N, N-diethyl-2-hydroxyphenylacetamide and analogue thereof and application thereof | 百新(北京)药业科技有限责任公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-115232020-A | Method for synthesizing N, N-diethyl-2-hydroxyphenylacetamide and analogue thereof and application thereof | 百新(北京)药业科技有限责任公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-106836233-B | A kind of carbon tetrachloride processing pond pure frame support device and its working method | 徐州腾睿智能装备有限公司 | 2019-06-21 | — | — | CN | disclosed |
| US-20180180992-A1 | Chemically Amplified Positive Resist Composition and Resist Pattern Forming Process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180180992-A1 | Chemically Amplified Positive Resist Composition and Resist Pattern Forming Process | POLI, POLL, SLC11A2 | TSHR 4760/4885GAA 104/4885KMT2A 965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.